Separating these possibilities without controlled studies remains impossible
Gasser, Lausanne (Psychiatrie)
The drug's mechanism involves activating GLP-1 and GIP receptorshormones produced in the intestines that prompt insulin release during meals
Together, this combination helps support: Muscle preservation Bone health Functional strength Cardiovascular fitness Long-term health and longevity Whether someone is taking a GLP-1 medication or not, maintaining muscle and bone strength becomes increasingly important as we age
Once released, it does several things at once: it prompts your pancreas to release insulin proportional to your current glucose level, signals your brain that you're full, slows the rate at which food leaves your stomach, and suppresses glucagon - the hormone that would otherwise push glucose higher between meals
This pre-systemic breakdown drastically reduces the amount of L-arginine that actually makes it into circulation, limiting its impact on nitric oxide production